Peer Review reports
From: Safety profile of faricimab: a multi-source pharmacovigilance analysis using FAERS and JADER
| Original Submission | ||
|---|---|---|
| 20 Dec 2024 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 15 Feb 2025 | Reviewed | Reviewer Report - Sahebaan Sethi |
| 22 Feb 2025 | Reviewed | Reviewer Report |
| 6 Mar 2025 | Author responded | Author comments - Yu Gao |
| Resubmission - Version 3 | ||
| 6 Mar 2025 | Submitted | Manuscript version 3 |
| 8 Mar 2025 | Author responded | Author comments - Yu Gao |
| Resubmission - Version 4 | ||
| 8 Mar 2025 | Submitted | Manuscript version 4 |
| 9 Mar 2025 | Author responded | Author comments - Yu Gao |
| Resubmission - Version 5 | ||
| 9 Mar 2025 | Submitted | Manuscript version 5 |
| 10 Mar 2025 | Author responded | Author comments - Yu Gao |
| Resubmission - Version 6 | ||
| 10 Mar 2025 | Submitted | Manuscript version 6 |
| Publishing | ||
| 11 Mar 2025 | Editorially accepted | |
| 12 Apr 2025 | Article published | 10.1186/s40360-025-00902-6 |
You can find further information about peer review here.